Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,702,978
+$4,616,990 QoQ
Shares Held
132,513
+149.5% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. PCVX ranks #37 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,702,978 | 132,513 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,085,988 | 53,106 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,186,219 | 134,075 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,540,247 | 126,048 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,942,973 | 121,285 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,030,311 | 106,735 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,916,430 | 72,275 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,372,745 | 47,018 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,722,036 | 49,292 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,941,086 | 43,055 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,249,055 | 35,813 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,079,598 | 60,408 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,904,806 | 78,190 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,945,435 | 51,906 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $189,929 | 3,961 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,216 | 1,509 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,038 | 1,886 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $95,367 | 3,949 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $424,865 | 17,859 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,179 | 283 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,183 | 408 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $676,476 | 34,252 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $949,106 | 35,721 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $681,294 | 13,797 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||